The role of inflammation in depression: from evolutionary imperative to modern treatment target

By Andrew H. Miller, Charles L Raison. Nature reviews. Immunology, 2015

3,447 citations recorded by the source corpus.

Crosstalk between inflammatory pathways and neurocircuits in the brain can lead to behavioural responses, such as avoidance and alarm, that are likely to have provided early humans with an evolutionary advantage in their interactions with pathogens and predators. However, in modern times, such interactions between inflammation and the brain appear to drive the development of depression and may contribute to non-responsiveness to current antidepressant therapies. Recent data have elucidated the mechanisms by which the innate and adaptive immune systems interact with neurotransmitters and neurocircuits to influence the risk for depression. Here, we detail our current understanding of these pathways and discuss the therapeutic potential of targeting the immune system to treat depression.

Subfields: Behavioral Neuroscience, Biological Psychiatry, Social Psychology

View Paper: https://www.semanticscholar.org/paper/beb88ef66a88ce12f44f857fd516a2bfa59b1022

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Behavioral Neuroscience

  1. C. Nemeroff
  2. M. Del Giudice
  3. Steven W. Gangestad
  4. Eléonore Beurel
  5. M. Toups
  6. J. Cryan
  7. Ted G. Dinan
  8. E. Adam

In Biological Psychiatry

  1. J. Cryan
  2. Ted G. Dinan
  3. G. Clarke
  4. C. Stanton
  5. R. Stilling
  6. C. Nemeroff
  7. M. Del Giudice
  8. Steven W. Gangestad

In Social Psychology

  1. J. Cryan
  2. Ted G. Dinan
  3. G. Clarke
  4. M. Del Giudice
  5. C. Stanton
  6. Steven W. Gangestad
  7. R. Stilling
  8. C. Nemeroff

Citations in the corpus